IRIS
BENFAREMO, Devis
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.192
EU - Europa 1.843
AS - Asia 1.680
SA - Sud America 338
Continente sconosciuto - Info sul continente non disponibili 251
AF - Africa 139
OC - Oceania 3
Totale 8.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.104
IT - Italia 605
SG - Singapore 556
VN - Vietnam 358
CN - Cina 304
RU - Federazione Russa 303
BR - Brasile 252
HK - Hong Kong 151
DE - Germania 131
IE - Irlanda 131
UA - Ucraina 127
SE - Svezia 118
FR - Francia 112
GB - Regno Unito 93
IN - India 62
BD - Bangladesh 61
CI - Costa d'Avorio 60
FI - Finlandia 54
CA - Canada 40
NL - Olanda 35
DK - Danimarca 31
TR - Turchia 31
MX - Messico 30
MA - Marocco 27
AR - Argentina 26
JP - Giappone 26
PL - Polonia 26
AT - Austria 22
KR - Corea 22
IQ - Iraq 19
ZA - Sudafrica 19
CO - Colombia 17
TW - Taiwan 12
BE - Belgio 11
EC - Ecuador 11
ES - Italia 11
PH - Filippine 9
UZ - Uzbekistan 9
VE - Venezuela 9
LT - Lituania 8
SA - Arabia Saudita 8
TN - Tunisia 8
CL - Cile 7
ID - Indonesia 7
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
KE - Kenya 6
OM - Oman 6
PY - Paraguay 6
CH - Svizzera 5
GR - Grecia 5
PK - Pakistan 5
JO - Giordania 4
MY - Malesia 4
NI - Nicaragua 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
PE - Perù 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 8.196
Salva come PNG Salva come JPEG
Città #
Ashburn 767
Singapore 349
Chandler 330
Dallas 206
San Jose 201
Fairfield 173
Hong Kong 147
Jacksonville 139
Council Bluffs 131
Dublin 129
Des Moines 120
Ho Chi Minh City 120
New York 118
Boardman 91
Hanoi 86
Los Angeles 84
Wilmington 84
Woodbridge 82
Beijing 79
Seattle 78
Houston 74
Ancona 67
Centro 63
Lauterbourg 62
The Dalles 62
Abidjan 60
Moscow 60
Munich 51
Lawrence 49
Princeton 49
Ann Arbor 46
Milan 46
Cambridge 44
Redmond 40
Orem 34
San Mateo 33
São Paulo 30
Buffalo 29
Rome 29
Santa Clara 27
Chicago 26
London 26
Haiphong 25
Turin 25
San Diego 24
Helsinki 23
Tolentino 23
Warsaw 23
Brooklyn 22
Atlanta 20
Washington 20
Hefei 19
Chennai 18
Frankfurt am Main 18
Montreal 18
Turku 18
Johannesburg 14
Tokyo 14
Denver 13
Manchester 13
Poplar 13
Da Nang 12
Pune 12
San Francisco 11
Amsterdam 10
Boston 10
Brussels 10
Columbus 10
Iesi 10
Nuremberg 10
Phoenix 10
Marche 9
Mexico City 9
Tashkent 9
Baghdad 8
Brasília 8
Cagliari 8
Guangzhou 8
Monte San Pietrangeli 8
Mumbai 8
Norwalk 8
Shanghai 8
Vienna 8
Wuhan 8
Belo Horizonte 7
Miano 7
Stockholm 7
Amandola 6
Bắc Ninh 6
Charlotte 6
Medellín 6
Querétaro 6
St Louis 6
Toledo 6
West Jordan 6
Aversa 5
Biên Hòa 5
Calgary 5
Cleveland 5
Comunanza 5
Totale 5.190
Salva come PNG Salva come JPEG
Nome #
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 323
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 193
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 190
ACCURACY OF DUAL-ENERGY COMPUTED TOMOGRAPHY FOR THE DETECTION OF BONE MARROW EDEMA IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS 189
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 188
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 180
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 171
Diagnosis and management of leukocytoclastic vasculitis 171
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 170
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 167
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 165
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 162
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 153
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 151
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 150
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 150
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 150
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 145
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis 144
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 140
Certolizumab pegol for the treatment of psoriasis 140
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 138
A painful diagnosis 134
Biologics in inflammatory immune-mediated systemic diseases 133
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 133
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 132
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 131
Videofluorography swallow study in patients with systemic sclerosis: correlation with clinical and radiological features 131
Dual-energy computed tomography for the detection of sacroiliac joints bone marrow oedema in patients with axial spondyloarthritis 127
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 126
MULTICENTER VALIDATION OF THE DETECTION OF ARTHRITIS IN INFLAMMATORY BOWEL DISEASES (DETAIL) QUESTIONNAIRE FOR THE SCREENING OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 124
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 123
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 123
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 117
Patient reported outcomes and assessment of the quality of life in a cohort of patients affected by enteropathic spondyloarthritis: results of a monocentric prospective observational study at one year 117
Putative functional pathogenic autoantibodies in systemic sclerosis 117
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association 117
Biologics in inflammatory and immunomediated arthritis 112
A young man with persistent dyspepsia: The unexpected virtue of proton-pump inhibitors 106
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 102
Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature 101
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 100
Dolore Articolare Acuto 100
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 99
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 99
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 97
The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors 94
Current take on systemic sclerosis patients’ vaccination recommendations 93
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 92
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 91
Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study 89
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 88
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) 87
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 86
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 85
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients 85
Novel therapeutic approaches and treatment targets for psoriatic arthritis 84
Pre-scleroderma and new opportunities for preventive medicine 82
Widespread painful nodules in a patient with rheumatoid arthritis 82
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 80
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia 79
Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosis 78
Enteropathic spondyloarthritis: Results from a large nationwide database analysis 77
Is there a future for anti-cd38 antibody therapy in systemic autoimmune diseases? 74
Tocilizumab for severe COVID-19 pneumonia 70
Systemic Sclerosis: A Key Model of Endothelial Dysfunction 64
Skin ultrasound in systemic sclerosis: past, present and exciting future 64
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 57
Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature 49
Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach 28
Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study 21
Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis 14
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian study 13
The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort 9
Totale 8.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022357 0 41 22 6 9 40 6 14 32 36 78 73
2022/2023898 68 103 67 79 44 201 11 53 187 10 59 16
2023/2024622 70 14 51 63 86 139 25 26 9 80 14 45
2024/20251.288 177 91 20 32 68 60 170 58 216 70 149 177
2025/20263.617 287 207 198 335 438 245 579 359 299 332 155 183
2026/2027490 415 75 0 0 0 0 0 0 0 0 0 0
Totale 8.446